Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Total Liabilities (2020 - 2025)

Historic Total Liabilities for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $32.6 million.

  • RxSight's Total Liabilities fell 194.23% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year decrease of 194.23%. This contributed to the annual value of $37.3 million for FY2024, which is 6822.16% up from last year.
  • Latest data reveals that RxSight reported Total Liabilities of $32.6 million as of Q3 2025, which was down 194.23% from $31.0 million recorded in Q2 2025.
  • RxSight's Total Liabilities' 5-year high stood at $60.3 million during Q4 2022, with a 5-year trough of $19.2 million in Q1 2024.
  • For the 5-year period, RxSight's Total Liabilities averaged around $41.6 million, with its median value being $37.7 million (2023).
  • In the last 5 years, RxSight's Total Liabilities crashed by 6655.95% in 2024 and then soared by 7533.79% in 2025.
  • Quarter analysis of 5 years shows RxSight's Total Liabilities stood at $54.5 million in 2021, then rose by 10.62% to $60.3 million in 2022, then tumbled by 63.18% to $22.2 million in 2023, then soared by 68.22% to $37.3 million in 2024, then dropped by 12.76% to $32.6 million in 2025.
  • Its last three reported values are $32.6 million in Q3 2025, $31.0 million for Q2 2025, and $33.7 million during Q1 2025.